Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients

Optimal care for breast cancer patients undergoing aromatase inhibitor (AI) treatment is ensured when estradiol (E(2)) levels are adequately suppressed. To assess treatment efficacy accurately, it is important to measure the serum E(2) levels using a well validated assay method with high sensitivity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jaque, Jenny, Macdonald, Heather, Brueggmann, Doerthe, Patel, Sherfaraz K, Azen, Colleen, Clarke, Nigel, Stanczyk, Frank Z
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2013
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3599208/
https://ncbi.nlm.nih.gov/pubmed/23520572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-2-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados